| Literature DB >> 35621938 |
Xu Hu1,2, Yuqi Tang1, Yuanyuan Liu1, Xinwei Pei1, Ziwei Huang1, Fuhang Song3, Huawei Zhang1.
Abstract
Chrysomycin A is one of the most promising therapeutic candidates for treating infections caused by multidrug-resistant Gram-positive bacteria. By hybridizing next-step generation (Illumina) and third-generation (PacBio) sequencing technologies, a high-quality chromosome-level genome together with a plasmid was firstly assembled for chrysomycin A-producing marine strain 891. Phylogenetic analysis of the 16S rRNA gene and genome sequences revealed that this strain unambiguously belonged to the genus Streptomyces, and its genomic features and functional genes were comprehensively analyzed and annotated. AntiSMASH analysis of this strain unveiled one key biosynthetic gene cluster, T2PKS, responsible for the biosynthesis of chrysomycin, the biosynthesis pathway of which was putatively proposed. These findings definitely shed light on further investigation for construction of a robust industrial strain with high-yield chrysomycin A production using genetic engineering techniques and combinatorial biology approaches.Entities:
Keywords: Streptomyces; chrysomycin A; gene mining; marine strain; whole-genome
Mesh:
Substances:
Year: 2022 PMID: 35621938 PMCID: PMC9144908 DOI: 10.3390/md20050287
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 6.085
Figure 1Chemical structure of chrysomycin A.
Figure 2Colony (a) and microscopic (b) morphology of marine strain 891.
Figure 3The 16S rRNA gene sequences-based phylogenetic tree of strain 891; all strains from the NCBI rRNA/ITS database.
Figure 4Whole genome sequence-based phylogenetic tree of strain 891; all strains from the NCBI Genome database.
Genomic features and annotation of strain 891.
| Features | Chromosome | Plasmid |
|---|---|---|
| Genome topology | linear | linear |
| Genome size (bp) | 7,804,062 | 35,476 |
| GC content (%) | 71.11 | 68.31 |
| Open reading frames | 6871 | 37 |
| Gene total length (bp) | 6,656,877 | 30,870 |
| Gene density (genes per kb) | 0.88 | 1.043 |
| Longest gene length (bp) | 78,261 | 4968 |
| Gene average length (bp) | 968.84 | 834.32 |
| GC content in gene region (%) | 71.44 | 68.62 |
| rRNA genes | 18 | 0 |
| tRNA genes | 57 | 0 |
| ncRNA genes | 103 | 0 |
| Secondary metabolite BGCs | 26 | 0 |
| Genes assigned to Swiss-Prot | 4236 | 5 |
| Genes assigned to KEGG | 2232 | 2 |
| Genes assigned to GO | 4675 | 7 |
| Genes assigned to NR | 6581 | 25 |
| Genes assigned to COG | 5808 | 11 |
| Genes assigned to CARD | 55 | 0 |
| Genes assigned to CAZy | 250 | 0 |
| CRISPR repeats | 15 | 0 |
| GenBank accession number | CP050693 | CP050694 |
Location of CRISPR-associated genes and repeats in strain 891.
| Positions | Functions | |
|---|---|---|
| CRISPR repeat No.1 | 7,701,174–7,702,715 | CRISPR repeat sequences |
| 7,703,460–7,703,765 | CRISPR-associated endoribonuclease Cas6 | |
| 7,705,207–7,706,280 | type I-B CRISPR-associated protein Cas7/Cst2/DevR | |
| 7,706,474–7,707,001 | CRISPR-associated protein Cas5 | |
| 7,707,097–7,709,430 | CRISPR-associated helicase/endonuclease Cas3 | |
| 7,709,427–7,709,942 | CRISPR-associated protein Cas4 | |
| 7,709,942–7,710,922 | CRISPR-associated protein Cas1 | |
| 7,711,064–7,711,192 | CRISPR-associated protein Cas2 | |
| CRISPR repeat No.2 | 7,712,784–7,714,256 | CRISPR repeat sequences |
Figure 5Functional gene annotation of strain 891: (a) Orthologous Groups of proteins (COG) analysis; (b) Gene Ontology (GO) analysis; (c) Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis.
Figure 6General chromosome features of strain 891. (From outside to inside, putative prophages, Genomics Islands, VFs; putative biosynthetic gene clusters; AbR genes on the forward strand; AbR genes on the reverse strand; putative protein-encoding sequences (CDSs) on the forward strand; CDSs on the reverse strand; and GC content, GC skew+, GC skew−).
Figure 7Comparison of chrysomycin BGC in strain 891 with that in strain FN566166.1 (a) and putative biosynthetic pathway for chrysomycin A in strain 891 (b).